Takeda appoints Sanofi's Andrew Plump to lead global R&D

TOKYO, Dec 18 (Reuters) - Takeda Pharmaceutical Co Ltd said on Thursday it had appointed Andrew Plump as chief medical and scientific officer to lead its global research and development operations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.